WULANDARI, F.; IKAWATI, M.; NOVITASARI, D.; KIRIHATA, M.; KATO, J.- YA; MEIYANTO, E. New curcumin analog, CCA-1.1, synergistically improves the antiproliferative effect of doxorubicin against T47D breast cancer cells. Indonesian Journal of Pharmacy, v. 31, n. 4, p. 244-256, 7 Dec. 2020.